证券代码：603231 证券简称：索宝蛋白 公告编号：2025-033 宁波索宝蛋白科技股份有限公司 第三届董事会第六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责 任。 宁波索宝蛋白科技股份有限公司（以下简称"公司"）第三届董事会第六次 会议于 2025 年 11 月 12 日以邮件等方式发出会议通知和材料，并于 2025 年 11 月 17 日在公司会议室以现场结合通讯表决方式召开会议。会议应出席董事 6 名， 实际出席 6 名，会议由董事长刘季善先生主持召开，高级管理人员列席会议。会 议召开符合法律法规、《公司法》及《公司章程》的规定，会议决议合法、有效。 会议审议通过以下议案： （一）审议通过《关于开立募集资金专项账户并签订募集资金四方监管协议 的议案》 特此公告。 宁波索宝蛋白科技股份有限公司董事会 2025 年 11 月 18 日 （二）审议通过《关于使用暂时闲置募集资金进行现金管理及以协定存款方 式存放募集资金余额的议案》 同意在确保不影响募集资金投资项目建设和募集资金使用的情况下，使用最 高额度不超 ...

Group 1 - The core point of the article is that Suobao Protein (SH 603231) held its third board meeting on November 17, 2025, to discuss the establishment of a special fundraising account and sign a four-party supervision agreement for the raised funds [1] - For the fiscal year 2024, Suobao Protein's revenue composition is heavily weighted towards the agricultural and sideline food processing industry, accounting for 99.61% of total revenue, while other businesses contribute only 0.39% [1] - As of the report date, Suobao Protein has a market capitalization of 4 billion yuan [1]

Core Insights - The plant protein industry, particularly soybean protein, is experiencing rapid growth due to increasing awareness of health and nutrition, with the market size in China projected to reach 16.161 billion yuan in 2024, a year-on-year increase of 4.47% [1][10]. Overview - Protein is essential for life and is composed of amino acids, with 20 types in total. Among these, 8 are essential and must be obtained from food. Plant proteins, particularly from beans, are lower in cholesterol and saturated fats, making them suitable for individuals with liver diseases and for preventing cardiovascular diseases [2][4]. Industry Barriers - The soybean protein industry is subject to strict regulations and quality control measures, including licensing and traceability requirements. New entrants face high technical barriers due to the established production processes and technology of existing players [6][7]. Market Policies - The Chinese government has implemented various policies to enhance soybean self-sufficiency and ensure quality control in soybean protein production. These policies promote the development of the soybean industry and require strict adherence to safety and quality standards [8]. Industry Chain - The soybean protein industry encompasses upstream activities such as soybean cultivation and procurement, midstream production, and downstream applications in various sectors including meat processing, snacks, dairy, and pharmaceuticals. The cost structure indicates that direct materials account for over 60% of production costs, with soybean being the primary raw material [8][9]. Current Development - Soybean is recognized for its high protein content and nutritional value, with various health benefits including cholesterol reduction and improved gut health. The domestic market for soybean protein is maturing rapidly, with significant growth in applications across multiple sectors [10][11]. Competitive Landscape - The soybean protein industry in China has seen the emergence of several key players, including Shandong Yuwang Ecological Food Co., Ltd., and Ningbo Suobao Protein Technology Co., Ltd. These companies are expanding their product offerings and market presence [11][12]. Future Trends - The soybean protein industry is shifting towards high-end products, with increasing production of high-purity and organized proteins. Innovations in processing technologies are expected to enhance the application of soybean protein in emerging fields such as pharmaceuticals and 3D printing [14][15].

Group 1 - The core viewpoint of the article is that Haitong International has given a "better than market" rating to Suobao Protein (603231.SH) based on its strong financial performance and growth prospects [1] Group 2 - Revenue showed steady growth in the first three quarters, with significant profit expansion [1] - In the third quarter, revenue accelerated, leading to faster profit growth [1] - The company is expanding its overseas market presence, with noticeable effects in cost reduction and efficiency improvement [1]

Group 1 - Company plans to repurchase shares worth between 50 million to 100 million yuan at a price not exceeding 14.00 yuan per share to reduce registered capital [1] - Company is engaged in investment operations, environmental engineering EPC, water treatment equipment production and sales, and water environment design consulting [1] Group 2 - Company announced a change in its joint venture investment project to a "100,000 tons/year waste rubber green low-carbon recycling preparation of carbon-based new materials project" with a total investment of 88 million yuan for the first phase [2][3] Group 3 - Company received an administrative regulatory measure decision from the Beijing Securities Regulatory Commission due to the failure to timely disclose the judicial freeze of shares [4] - The controlling shareholder's shares were frozen, accounting for 13.9% of the total share capital [4] Group 4 - Company is in the product development stage for its embodied intelligent robot business, which has not yet achieved mass production or revenue generation [5][6] Group 5 - Shareholders plan to reduce their holdings by up to 2.98% of the company's total shares through various trading methods [7][8] - Company specializes in the research, design, manufacturing, and sales of material handling equipment [9] Group 6 - Shareholders plan to reduce their holdings by up to 3% of the company's total shares [10][11] Group 7 - Shareholders plan to reduce their holdings by up to 1% of the company's total shares [12][18] Group 8 - Company announced the receipt of a property with an estimated value of 133 million yuan, which is expected to increase pre-tax profits by approximately 130 million yuan for the 2025 fiscal year [17][18] Group 9 - Company announced that its main product, phosphorus trichloride, is primarily used in the production of water treatment agents [19] - The company is facing risks related to the administrative approval process for a project that is behind schedule [19] Group 10 - Controlling shareholders plan to reduce their holdings by up to 3.66% of the company's total shares [20][21] Group 11 - Company signed a strategic framework agreement with a robotics company to collaborate on applications in intelligent manufacturing [22] Group 12 - Company plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [23] Group 13 - Controlling shareholder plans to transfer 5% of the company's shares as part of a cash acquisition arrangement [24] Group 14 - Company announced a change in control with a new controlling party following a share transfer agreement [25] Group 15 - Company plans to transfer 60% of its subsidiary's equity at a base price of 1.6756 million yuan, which is expected to reduce net profit by approximately 26.4 million yuan for the 2025 fiscal year [26] Group 16 - Major shareholder plans to provide a loan of up to 1.666 billion yuan to the company for debt repayment purposes [27]

Mergers and Acquisitions - DingTong Technology plans to acquire 70% stake in Blue Ocean Vision for 126 million yuan, making it a subsidiary after the transaction [1] - Dongfang Zhizao intends to purchase 70% stake in Nantong Saifu Machinery Equipment for 27.4887 million yuan using its own funds [3] Shareholding Changes - Sobor Protein's shareholder Jinan Fosun and its concerted parties plan to reduce their holdings by up to 574.38 thousand shares, representing 3% of the total share capital [4] - Hetai Electromechanical's shareholder Hangzhou Haitai Jinghua plans to reduce its holdings by up to 195.98 thousand shares, accounting for 2.98% of the total share capital [5] - Hongtong Gas's shareholder Tian Hui intends to reduce his holdings by up to 848.64 thousand shares, which is not more than 3% of the total share capital [6] - Zhonggu Logistics's shareholder Ningbo Guyang Investment plans to reduce its holdings by up to 3% of the total share capital [7] Risk Matters - ST Chang Pharmaceutical faces a risk of delisting due to a cumulative price drop of 34.98% over two consecutive trading days, linked to an investigation by the Securities Regulatory Commission for suspected false financial reporting [8]

Mergers and Acquisitions - DingTong Technology plans to acquire 70% equity of Blue Ocean Vision for 126 million yuan, making it a subsidiary after the transaction [1] - Dongfang Zhizao intends to purchase 70% equity of Nantong Saifu Machinery Equipment for 27.4887 million yuan using its own funds [3] - Bangji Technology has terminated its plan to acquire 100% equity of Shandong Beixi Agricultural and Animal Husbandry Co., Ltd. and 80% equity of Paistong Livestock Technology Consulting (Shanghai) Co., Ltd. [2] Shareholding Changes - Sobao Protein's shareholder Jinan Fosun and its concerted parties plan to reduce their holdings by up to 3%, totaling a maximum of 574.38 million shares [4] - Hetai Electromechanical's shareholder Hangzhou Hetai Jinghua plans to reduce its holdings by up to 2.98%, equating to a maximum of 195.98 million shares [5] - Hongtong Gas's shareholder Tian Hui intends to reduce his holdings by up to 3%, which amounts to a maximum of 848.64 million shares [6] - Zhonggu Logistics's shareholder Ningbo Guyang Investment Management plans to reduce its holdings by up to 3% [7] Risk Matters - ST Chang Pharmaceutical's stock has experienced a cumulative decline of 34.98% over two consecutive trading days, indicating a risk of delisting due to abnormal fluctuations and ongoing investigations by the regulatory authority [8]

Company Announcements - *ST Zhengping has completed the stock suspension review and will resume trading on November 12, confirming normal production and operation without significant changes [1] - Upwind New Materials is in the product development stage for its embodied intelligent robot business, which has not yet achieved mass production or revenue generation [2] - Shannon Chip Innovation's fourth largest shareholder, Shenzhen Xinlianpu, has pledged 1.27 million shares for financing purposes [3] - Qing Shui Yuan's phosphorus trichloride products are primarily used in the production of water treatment agents [4] - Midea Group announced a cash dividend plan of 5 yuan per 10 shares, totaling 3.448 billion yuan, with the record date on November 17 [4] - Huiyuan Communication is planning a change of control, leading to a stock suspension starting November 12 [5] - Shen Gong Co. has clarified that some research reports on its performance forecasts represent only analysts' personal views [6] - World is developing diamond micro-drills for PCB processing, which are still in the R&D phase [6] - Haike New Source has signed an agreement with Kunlun New Materials for the purchase of 596,200 tons of electrolyte solvent [7] - Tongxing Technology plans to invest 3.2 billion yuan in a project to produce 100,000 tons of sodium battery cathode materials and 6 GWh battery cells [8] Investments & Contracts - Zhongjin Irradiation is investing 200 million yuan to build an electronic accelerator intelligent manufacturing project [10] - Hongri Da is collaborating with Te Du Technology and Hongke Tongchuang to establish a joint venture for semiconductor packaging [10] Shareholding Changes - Jian Kai Technology's controlling shareholder Xuanzhao plans to transfer 3% of its shares through a pricing inquiry [12] - Yue Wannianqing's shareholder Hehe Investment intends to reduce its stake by up to 3% [14] Financing & Capital Increase - Weiteng Electric plans to raise up to 300 million yuan through a private placement for various manufacturing projects [22] Other Developments - Zhifei Biological has received approval for clinical trials of a vaccine for adolescents and adults [23] - Shanghai Kaibao has obtained approval for clinical trials of a drug for acute ischemic stroke [24]

证券代码：603231 证券简称：索宝蛋白 公告编号：2025-031 宁波索宝蛋白科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股东的基本情况 截至本公告披露日，宁波索宝蛋白科技股份有限公司(以下简称"公司") 的股东济南财金复星惟实股权投资基金合伙企业(有限合伙)(以下简称"济南复 星")持有公司股份 13,473,046 股，占公司总股本的 7.037%，其一致行动人上 海复星创富投资管理股份有限公司－宁波梅山保税港区复星惟盈股权投资基金 合伙企业(有限合伙)（以下简称"宁波复星"）持有公司股份 13,473,046 股，占 公司总股本的 7.037%。上述股份的来源均为公司 IPO 前取得的股份，已于 2024 年 12 月 16 日上市流通。济南复星与宁波复星为一致行动人关系，合计持有公司 股份 26,946,092 股，占公司总股本的 14.074%。 减持计划的主要内容 济南复星、宁波复星处于自身经营发展需要，拟通过集中竞价或大宗交易方 式减持公 ...

Core Viewpoint - The company, Sobo Protein (603231.SH), announced that Jinan Fosun and Ningbo Fosun plan to reduce their holdings in the company by a total of up to 5.7438 million shares, which represents no more than 3% of the company's total share capital [1] Summary by Category - **Shareholding Reduction** - Jinan Fosun and Ningbo Fosun intend to reduce their stakes in Sobo Protein through centralized bidding or block trading [1] - The total number of shares to be reduced is up to 5.7438 million [1] - This reduction accounts for a maximum of 3% of the company's total share capital [1]